Strømhaug P E, Berg T O, Berg K, Seglen P O
Department of Tissue Culture, Norwegian Radium Hospital, Montebello, Oslo, Norway.
Biochem J. 1997 Jan 1;321 ( Pt 1)(Pt 1):217-25. doi: 10.1042/bj3210217.
A photoactivatable porphyrin, tetra(4-sulphonatophenyl)porphine (TPPS4), was shown to accumulate in rat hepatocytes as a linear function of dose after intravenous injection, and to localize predominantly in hepatocytic lysosomes. A major fraction of the lysosomal enzymes acid phosphatase and N-acetyl-beta-D-glucosaminidase was inactivated by TPPS4 after 20 h of contact with the drug in vivo in the absence of photoactivation. On exposure of isolated hepatocytes to light, photoactivated TPPS4 caused additional inactivation of the lysosomal enzymes as well as inactivation of intralysosomal lactate dehydrogenase (LDH), a cytosolic enzyme that accumulated in lysosomes as a result of autophagy during a 2 h incubation of hepatocytes at 37 degrees C in the dark (in the presence of the proteinase inhibitor leupeptin to prevent degradation of intralysosomal LDH). Photoactivation of TPPS4 also induced lysosomal rupture, with a loss of lysosomal enzymes, autophagocytosed LDH, endocytosed 125I-tyramine-cellobiose-asialo-orosomucoid and TPPS4 from the lysosomes. However, LDH-containing autophagosomes, accumulated in the presence of vinblastine (a microtubule inhibitor used to prevent the fusion of lysosomes with autophagosomes or endosomes), were not affected by TPPS4. TPPS4 may thus be useful as a selective lysosomal (or endosomal) perturbant in the study of autophagic-endocytic-lysosomal interactions.
一种可光激活的卟啉,四(4 - 磺酸苯基)卟啉(TPPS4),静脉注射后在大鼠肝细胞中的积累呈剂量线性函数关系,且主要定位于肝细胞溶酶体。在体内与药物接触20小时且无光激活的情况下,溶酶体酶酸性磷酸酶和N - 乙酰 - β - D - 氨基葡萄糖苷酶的一大部分被TPPS4灭活。将分离的肝细胞暴露于光下,光激活的TPPS4会导致溶酶体酶进一步失活,以及溶酶体内乳酸脱氢酶(LDH)失活,LDH是一种胞质酶,在37℃黑暗中肝细胞孵育2小时(在存在蛋白酶抑制剂亮肽素以防止溶酶体内LDH降解的情况下)因自噬而积累在溶酶体中。TPPS4的光激活还诱导溶酶体破裂,导致溶酶体酶、自噬吞噬的LDH、内吞的125I - 酪胺 - 纤维二糖 - 去唾液酸 - 血清类黏蛋白和TPPS4从溶酶体中丢失。然而,在长春花碱(一种用于防止溶酶体与自噬体或内体融合的微管抑制剂)存在下积累的含LDH自噬体不受TPPS4影响。因此,TPPS4在自噬 - 内吞 - 溶酶体相互作用的研究中可能作为一种选择性溶酶体(或内体)干扰剂有用。